TABLE 2.

Treatment Characteristics

Characteristic	All patients (n = 90)	PET-positive (n = 42)	PET-negative (n = 48)
ADT with stop before last follow-up/duration (mo)	23/5 (2–23)	23/5 (2–23)	—
Ongoing ADT at last follow-up (n)	3	2	1
No ADT (n)	64	17	47
Median PSA before radiation therapy (ng/mL)	0.44 (0.11–6.24)	0.68 (0.3–6.24)	0.34 (0.11–3.24)
Radiation therapy* (Gy)
Former prostate	66 (59.4–70.2)
Lymphatic pathways	50.4 (45–50.4)
PET-positive local recurrence	70.0 (67.2–72)
PET-positive lymph node	60.76 (54–66)

^*Radiation therapy technique for all patients was volume-modulated arc therapy/intensity-modulated radiotherapy and image-guided radiotherapy.

Data in parentheses are ranges.